Skip to content

Noopept

PeptidespeptideEarly stage

Availability Regulator warning issued

What it is

Noopept, generic name omberacetam, is a synthetic dipeptide developed in Russia and registered there as a nonprescription medicine for cognitive and asthenic disorders. It is a proline-containing relative of the racetam family rather than a signaling peptide, active at milligram doses where piracetam needs grams.

Why people take it

It is the cheapest, most available entry point in the whole nootropic category, taken orally, sold without a prescription, and reviewed endlessly online. People take it wanting sharper recall and steadier concentration through demanding work, or as a first experiment before anything injectable.

How it's delivered

Oral capsules or powder bought from internet sellers. Its US status is the part most buyers miss: FDA has stated plainly that omberacetam does not meet the definition of a dietary ingredient and cannot lawfully be marketed in a supplement. FDA has issued warning letters to nootropic sellers, including one in February 2019, and has used import alerts against it. Products carrying it are unapproved new drugs, not supplements.

Where the evidence stands

Weak where it matters most. The clinical file is Russian, older, and mostly in post-stroke, post-concussion, and asthenic populations rather than healthy adults, with reporting no modern regulator would accept. Laboratory work is more concrete, showing neuroprotection and reduced tau hyperphosphorylation in Alzheimer's cell models. Separately, an analysis in Neurology Clinical Practice found omberacetam among five unapproved drugs turning up in US cognitive-enhancement supplements, sometimes above pharmaceutical doses and often mislabelled.

Estimated cost

  • Sold as a supplement despite FDA saying it is not one
  • No approved US product and no list price
  • Not covered by insurance

Who offers it

No clinic or telehealth provider in our research pass listed noopept. It reaches people through internet nootropic sellers operating against FDA's stated position, where label accuracy has repeatedly failed independent testing.

How we know

Recorded from FDA enforcement records and the published literature on our last research pass. We list no referral path to this compound and are not compensated for this entry.

Go deeper

No cognitive peptides guide yet. The Peptide Explorer entry carries the compound record, and the peptide therapy hub covers what separates an approved medicine from a research chemical wearing a supplement label.

Noopept in the Peptide Explorer · Peptide Therapy for Longevity

Longevity.io is for educational purposes only and is not medical advice. We list noopept so the regulatory record is clear, not because an unapproved drug sold as a supplement belongs in a plan. Confirm any claim against FDA's own enforcement record.

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint